These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1398236)

  • 41. Hypouricemia in cirrhosis reflects hemodynamic alterations.
    Decaux G; Mols P; Naeije R; Reding P
    Metabolism; 1984 Aug; 33(8):750-3. PubMed ID: 6748949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
    Gerbes AL; Gülberg V; Waggershauser T; Holl J; Reiser M
    Hepatology; 1998 Sep; 28(3):683-8. PubMed ID: 9731559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of V1a receptor increases renal uric acid clearance via urate transporters: insight into pathogenesis of hypouricemia in SIADH.
    Taniguchi K; Tamura Y; Kumagai T; Shibata S; Uchida S
    Clin Exp Nephrol; 2016 Dec; 20(6):845-852. PubMed ID: 26935049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of volume expansion, serum sodium, and fractional excretion of sodium on urate excretion.
    Diamond H; Meisel A
    Pflugers Arch; 1975 Apr; 356(1):47-57. PubMed ID: 1238979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of effect of salt intake on urinary uric acid excretion.
    Breslau NA; Pak CY
    J Urol; 1983 Mar; 129(3):531-2. PubMed ID: 6834539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hypouricaemia in the syndrome of inappropriate ADH secretion (SIADH) (author's transl)].
    Ducobu J; Dupont P
    Nouv Presse Med; 1982 Mar; 11(12):915-6. PubMed ID: 7063367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
    Martin PY; Ohara M; Gines P; Xu DL; St John J; Niederberger M; Schrier RW
    J Clin Invest; 1998 Jan; 101(1):235-42. PubMed ID: 9421486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clearance, reabsorption and excretion of free and bound L-carnitine in children].
    Karpowicz B; Kuchta G; Marczak E; Rutkowski B; Lysiak-Szydlowska W
    Pol Tyg Lek; 1995 Sep; 50(36-39):42-4. PubMed ID: 8650031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Blood volume and urinary sodium, potassium and uric acid in cirrhosis. Evidence of the hypersensitivity of the nephron to aldosterone].
    Decaux G; Hanson B; Cauchie P; Bosson D; Unger J
    Acta Gastroenterol Belg; 1986; 49(1):13-9. PubMed ID: 3766056
    [No Abstract]   [Full Text] [Related]  

  • 52. Uric acid and urea in human sweat.
    Huang CT; Chen ML; Huang LL; Mao IF
    Chin J Physiol; 2002 Sep; 45(3):109-15. PubMed ID: 12817713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure.
    Gülberg V; Møller S; Henriksen JH; Gerbes AL
    Gut; 2000 Dec; 47(6):852-7. PubMed ID: 11076886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.
    Bernardi M; Trevisani F; Santini C; De Palma R; Gasbarrini G
    Gut; 1983 Aug; 24(8):761-6. PubMed ID: 6347831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Directional velocity of the arterial flow, systemic vascular resistance and urinary excretion of sodium in cirrhotic patients].
    Aliaga L; Mediavilla JD; Omar M; Zozaya JM; Prieto J
    Presse Med; 1995 Apr; 24(16):758-62. PubMed ID: 7784414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral Salt-Wasting Syndrome: Diagnosis by Urine Sodium Excretion.
    Arieff AI; Gabbai R; Goldfine ID
    Am J Med Sci; 2017 Oct; 354(4):350-354. PubMed ID: 29078838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver.
    Jalan R; Kapoor D
    Gut; 2003 Jul; 52(7):1041-5. PubMed ID: 12801964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.
    Decaux G; Unger J; Brimioulle S; Mockel J
    JAMA; 1982 Jan 22-29; 247(4):471-4. PubMed ID: 7054549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults.
    Shoaf SE; Bricmont P; Dandurand A
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1399-1408. PubMed ID: 28803333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.